Status:
UNKNOWN
PCL (Poly-ε-caprolactone) Mesh Pleurodesis
Lead Sponsor:
National Taiwan University Hospital
Conditions:
PCL Pleurodesis
Eligibility:
All Genders
18-50 years
Phase:
EARLY_PHASE1
Brief Summary
Recent advances in thoracoscopic surgery have made it a commonly used technique for treating spontaneous pneumothoraces and preventing recurrence. The goal of surgical treatment is to find the offendi...
Detailed Description
Primary spontaneous pneumothorax usually occurs in young, lean young men. In most cases, the cause of pneumothorax is rupture of blebs at the apex of the lung. Traditionally, bullectomy with mechanica...
Eligibility Criteria
Inclusion
- Primary spontaneous pneumothorax patients who require thoracoscopic bullectomy and pleurodesis
Exclusion
- chronic obstructive pulmonary disease, hemopneumothorax, catamenial pneumothorax, pregnant, malignancy
Key Trial Info
Start Date :
August 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 31 2019
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT03227978
Start Date
August 1 2017
End Date
July 31 2019
Last Update
July 24 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.